Literature DB >> 2572297

Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminal alpha 2-adrenergic autoreceptors.

O Curet1, C de Montigny.   

Abstract

The present electrophysiological studies were undertaken to assess the role of terminal alpha 2-adrenergic autoreceptors in regulating noradrenergic synaptic transmission in the rat CNS. The effectiveness of the electrical stimulation of the locus coeruleus (LC) in suppressing the firing activity of pyramidal neurons was determined in the dorsal hippocampus. Intravenous clonidine, an alpha 2-adrenergic agonist, decreased the effectiveness of the LC stimulation, without altering the effect of microiontophoretically applied norepinephrine. The subsequent i.v. administration of low doses of idazoxan, an alpha 2-adrenergic antagonist, reversed this effect of clonidine on the LC stimulation. To ascertain that the effect of clonidine administered i.v. was indeed attributable to its action on noradrenergic terminals, it was applied locally by microiontophoresis; it decreased the effectiveness of the LC stimulation. Another paradigm used to assess the function of terminal alpha 2-adrenoceptors was to increase the frequency of the LC stimulation from 1 to 5 Hz. This resulted in a 5-fold decrease of the effectiveness of the stimulation. That this was attributable to an enhanced activation of terminal alpha 2-adrenoceptors was suggested by the reversal of this effect of increasing the frequency of the LC stimulation by intravenous idazoxan. Furthermore, the degree of enhancement of the effectiveness of the LC stimulation by idazoxan was much greater at 5 than at 1 Hz. These results provide novel electrophysiological evidence for the potent regulatory role of terminal alpha 2-adrenoceptors on noradrenergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572297     DOI: 10.1016/0006-8993(89)91131-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation.

Authors:  Stella Manta; Jianming Dong; Guy Debonnel; Pierre Blier
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

Review 2.  The locus coeruleus and central chemosensitivity.

Authors:  Luciane H Gargaglioni; Lynn K Hartzler; Robert W Putnam
Journal:  Respir Physiol Neurobiol       Date:  2010-05-08       Impact factor: 1.931

3.  Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion.

Authors:  Ramez Ghanbari; Mostafa El Mansari; Pierre Blier
Journal:  Psychopharmacology (Berl)       Date:  2011-03-29       Impact factor: 4.530

4.  The alpha 2-adrenergic antagonist idazoxan enhances the frequency selectivity and increases the threshold of auditory cortex neurons.

Authors:  J M Edeline
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

5.  Noradrenaline receptors participate in the regulation of GABAergic inhibition in area CA1 of the rat hippocampus.

Authors:  M Andreasen; J D Lambert
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

6.  Alpha 2-autoreceptor-mediated modulation of tyrosine hydroxylase activity in noradrenergic regions of the rat brain in vivo.

Authors:  F Pi; J A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

7.  In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus.

Authors:  R Mongeau; P Blier; C de Montigny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

8.  Serotonergic mechanisms on breathing modulation in the rat locus coeruleus.

Authors:  Vanessa de Souza Moreno; Kênia C Bícego; Raphael E Szawka; Janete A Anselmo-Franci; Luciane H Gargaglioni
Journal:  Pflugers Arch       Date:  2009-10-21       Impact factor: 3.657

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.